Norges Bank’s Esperion Therapeutics ESPR Stock Holding History

Norges Bank’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-735,900	Closed	-$1.17M	–	2044
2023 Q1	$1.17M	Hold	735,900	–	–	﹤0.01%	1987
2022 Q4	$4.58M	Buy	+735,900	New	+$5.26M	﹤0.01%	1805
2021 Q3	–	Sell	-189,931	Closed	-$4.02M	–	2295
2021 Q2	$4.02M	Sell	189,931 -38,012	-17%	-$915K	﹤0.01%	1936
2021 Q1	$6.39M	Sell	227,943 -39,617	-15%	-$1.17M	﹤0.01%	1878
2020 Q4	$6.96M	Sell	267,560 -7,192	-3%	-$215K	﹤0.01%	1831
2020 Q3	$10.2M	Sell	274,752 -26,021	-9%	-$1.03M	﹤0.01%	1702
2020 Q2	$15.4M	Sell	300,773 -12,796	-4%	-$535K	﹤0.01%	1581
2020 Q1	$9.89M	Hold	313,569	–	–	﹤0.01%	1624
2019 Q4	$18.7M	Hold	313,569	–	–	0.01%	1553
2019 Q3	$11.5M	Buy	313,569 +12,612	+4%	+$500K	﹤0.01%	1726
2019 Q2	$14M	Buy	300,957 +134,096	+80%	+$6.3M	﹤0.01%	1676
2019 Q1	$6.7M	Buy	166,861 +46,511	+39%	+$2.09M	﹤0.01%	1896
2018 Q4	$5.54M	Hold	120,350	–	–	﹤0.01%	1908
2018 Q3	$5.34M	Hold	120,350	–	–	﹤0.01%	1960
2018 Q2	$4.72M	Buy	120,350 +14,491	+14%	+$732K	﹤0.01%	1961
2018 Q1	$7.66M	Buy	+105,859	New	+$7.77M	﹤0.01%	1819
2016 Q2	–	Sell	-21,044	Closed	-$356K	–	2178
2016 Q1	$356K	Hold	21,044	–	–	﹤0.01%	2147
2015 Q4	$468K	Hold	21,044	–	–	﹤0.01%	2173
2015 Q3	$496K	Buy	+21,044	New	+$1.32M	﹤0.01%	2189

Other funds holding ESPR

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Norges Bank's ESPR Position: Q2 2023 in Review

Norges Bank sold out of Esperion Therapeutics (ESPR) in Q2 2023, closing a stake of 735,900 shares — an estimated $1.17M sold.

Norges Bank first reported a position in ESPR in Q3 2015 and held it in 19 quarters. The position peaked at $18.7M in Q4 2019. 124 funds tracked by Wall St. Rank hold ESPR as of Q2 2023.

Norges Bank reported no remaining Esperion Therapeutics position as of Q2 2023 after selling out during the quarter.
Norges Bank sold 735,900 Esperion Therapeutics shares in Q2 2023, an estimated $1.17M.
Norges Bank first reported a position in Esperion Therapeutics in Q3 2015 and held it in 19 quarters.
Norges Bank's Esperion Therapeutics position peaked at $18.7M in Q4 2019.
124 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2023.

Based on Norges Bank's 13F filing for Q2 2023, filed 14 Aug 2023.